Skip to content

MRI of Infrapatellar Fat Pad in Osteoarthritis

Magnetic Resonance Imaging of Infrapatellar Fat Pad in Osteoarthritis and Controls

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02829463
Acronym
IPFP-MRI
Enrollment
121
Registered
2016-07-12
Start date
2015-10-31
Completion date
2016-07-31
Last updated
2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

In this study, the investigators use the clinical documentation and imaging data of MRI to do research. Clinical subjects were divided into two groups: osteoarthritis patients and healthy controls without osteoarthritis. Differences of MRI data were studied between two groups.

Detailed description

In this study, the investigators applied high precision MRI technique (with as less as a slice thickness of 0.35 mm and without inter-slice gap), and calculated not only the IPFP maximal sagittal area and IPFP volume, but also the quantitated signal, and compared the differences between healthy controls and osteoarthritis patients. This is an observational cross-sectional study without specific interventions to the subjects. MRI is a regular examination in our hospital. And all subjects are included for the reasons of osteoarthritis (need MRI) and healthy controls (pain but not osteoarthritis, also need MRI). The investigator does not assign specific interventions to the subjects of the study.

Interventions

RADIATIONMagnetic resonance imaging

3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.

Sponsors

The Third Xiangya Hospital of Central South University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients with clinical knee osteoarthritis; * The healthy controls who require MRI test.

Exclusion criteria

* Contraindications to magnetic resonance imaging; * Rheumatoid arthritis patients; * Gout; * Hemophilic arthritis; * Subjects who take non-steroidal anti-inflammatory drugs (NSAIDs); * Subjects who take lipid-lowering agents; * Subjects who have the history of knee trauma; * Subjects who have the history of knee operation; * Subjects who have the disease of musculoskeletal tumor near knee; * Subjects who have joint loose bodies.

Design outcomes

Primary

MeasureTime frame
Infrapatellar Fat Pad Volume in MRIcollect the data within 24 hours after the subjects did the MRI

Countries

China

Participant flow

Participants by arm

ArmCount
Osteoarthritis Patients
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients with osteoarthritis. It's not the intervention the study applied, but the subjects' disease demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
59
Healthy Controls
3.0 Tesla Magnetic resonance imaging was analyzed. It's the documentation from the outpatients and inpatients without osteoarthritis. It's not the intervention the study applied, but the subjects' non-osteoarthritis knee symptom demands. Magnetic resonance imaging: 3.0 T Magnetic resonance imaging of knee joints. It does not harm the subjects.
62
Total121

Baseline characteristics

CharacteristicOsteoarthritis PatientsHealthy ControlsTotal
Age, Continuous59.6 years
STANDARD_DEVIATION 9.2
38.8 years
STANDARD_DEVIATION 13.6
49.9 years
STANDARD_DEVIATION 15.6
BMI24.7 kg/(m^2)
STANDARD_DEVIATION 3.5
22.6 kg/(m^2)
STANDARD_DEVIATION 4.4
23.6 kg/(m^2)
STANDARD_DEVIATION 4.1
Sex: Female, Male
Female
36 Participants29 Participants65 Participants
Sex: Female, Male
Male
23 Participants33 Participants56 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 590 / 62
serious
Total, serious adverse events
0 / 590 / 62

Outcome results

Primary

Infrapatellar Fat Pad Volume in MRI

Time frame: collect the data within 24 hours after the subjects did the MRI

ArmMeasureValue (MEAN)Dispersion
Osteoarthritis PatientsInfrapatellar Fat Pad Volume in MRI25154.96 mm^3Standard Deviation 4865.37
Healthy ControlsInfrapatellar Fat Pad Volume in MRI29202.39 mm^3Standard Deviation 7242.63

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026